Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2025-02-14 5:09 pm Sale |
2024-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Blue Owl Capital Holdings LP | 1,079,321 4.200% |
-451,080 (-29.47%) |
Filing History |
| 2024-11-14 5:46 pm Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
RA Capital Management, L.P. | 2,538,925 9.900% |
493,897 (+24.15%) |
Filing History |
| 2024-11-14 5:05 pm Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
Blue Owl Capital Holdings LP | 1,530,401 6.000% |
198,099 (+14.87%) |
Filing History |
| 2024-11-14 4:32 pm Unchanged |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
VIKING GLOBAL INVESTORS LP | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-11-14 09:45 am Sale |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
Deep Track Capital, LP | 0 0.000% |
-1,815,854 (Position Closed) |
Filing History |
| 2024-11-14 09:39 am Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
AVORO CAPITAL ADVISORS LLC | 2,222,222 8.700% |
2,222,222 (New Position) |
Filing History |
| 2024-11-08 2:17 pm Unchanged |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
BLACKROCK INC BLK |
1,753,347 6.800% |
0 (Unchanged) |
Filing History |
| 2024-10-22 6:06 pm Purchase |
2024-09-30 | 13G | Tourmaline Bio, Inc. TRML |
BLACKROCK INC BLK |
1,753,347 6.800% |
1,753,347 (New Position) |
Filing History |
| 2024-06-03 8:53 pm Purchase |
2024-05-23 | 13G | Tourmaline Bio, Inc. TRML |
RA Capital Management, L.P. | 2,045,028 8.000% |
2,045,028 (New Position) |
Filing History |
| 2024-03-15 07:45 am Unchanged |
2024-01-29 | 13G | Tourmaline Bio, Inc. TRML |
PFIZER INC PFE |
1,272,214 4.960% |
0 (Unchanged) |
Filing History |
| 2024-02-14 9:08 pm Purchase |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Hydra LLC | 1,702,164 6.600% |
500,000 (+41.59%) |
Filing History |
| 2024-02-14 8:51 pm Purchase |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Blue Owl Capital Holdings LP | 1,332,302 6.550% |
1,332,302 (New Position) |
Filing History |
| 2024-02-14 5:04 pm Unchanged |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
RA Capital Management, L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-14 4:57 pm Purchase |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Citadel Advisors LLC | 2,265 0.000% |
2,265 (New Position) |
Filing History |
| 2024-02-09 5:24 pm Unchanged |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
Blackstone Holdings II L.P. | 0 0.000% |
0 (Unchanged) |
Filing History |
| 2024-02-09 4:22 pm Purchase |
2024-01-29 | 13G | Tourmaline Bio, Inc. TRML |
TCG Crossover GP I, LLC | 1,477,593 5.900% |
1,477,593 (New Position) |
Filing History |
| 2024-02-07 2:11 pm Purchase |
2023-12-31 | 13G | Tourmaline Bio, Inc. TRML |
BML Investment Partners, L.P. | 245,500 1.000% |
245,500 (New Position) |
Filing History |
| 2023-11-06 4:30 pm Purchase |
2023-10-25 | 13G | Tourmaline Bio, Inc. TRML |
Hydra LLC | 1,202,164 5.900% |
1,202,164 (New Position) |
Filing History |
| 2023-10-30 5:16 pm Sale |
2023-10-19 | 13D | Talaris Therapeutics, Inc. TALS |
Longitude Capital Partners III LLC | 322,077 1.600% |
-1 (-0.00%) |
Filing History |
| 2023-10-30 4:15 pm Purchase |
2023-10-19 | 13D | Tourmaline Bio, Inc. TRML |
Qiming U.S. Healthcare GP II LLC | 646,770 3.200% |
646,770 (New Position) |
Filing History |